Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic Patients

Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in the Treatment of Patients With Acute Schizophrenia - a Multicentre, Double-Blind, Parallel Group, Randomized Study

The purpose of the study is to compare the safety and tolerability of IR (Immediate-Release) quetiapine in a rapid escalation scheme with to the current approved label titration.

Inclusion Criteria:

• Men and women age ≥18 to ≤65 years with acute schizophrenia
• Provision of written informed consent prior to enrolment

Exclusion Criteria:

• Meeting the criteria for any other (than schizophrenia) psychotic disorder not in full remission, concomitant organic mental disorder or mental retardation
• Patients with substance dependence
• Female patients who are pregnant, lactating or at risk of pregnancy